Paratek Pharmaceuticals

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Pharma

Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M

In a move to expand its portfolio beyond antibiotics, Paratek has bought out Optinose and its chronic rhinosinusitis nasal spray Xhance for $330M.

Kevin Dunleavy Mar 20, 2025 11:23am

Nuzyra bottle and pills

Paratek's pneumonia antibiotic Nuzyra clinches trial win

Jul 19, 2024 8:28am

Nuzyra bottle and pills

Paratek's $462M sale under threat from investor NexPoint

Jun 28, 2023 2:03pm

Photo of two hands shaking

Paratek bought by Novo Holdings, Gurnet Point for $462M

Jun 6, 2023 4:21pm

American flag

What will become of Trump's 'onshore' drug production effort?

Dec 22, 2020 3:00am

Grand River Aseptic Manufacturing

Michigan CDMO builds new plant to meet U.S.-made drug demand

Jun 30, 2020 9:00am